WO2010104336A3 - 아연 분말을 이용한 메로페넴의 개선된 제조방법 - Google Patents

아연 분말을 이용한 메로페넴의 개선된 제조방법 Download PDF

Info

Publication number
WO2010104336A3
WO2010104336A3 PCT/KR2010/001516 KR2010001516W WO2010104336A3 WO 2010104336 A3 WO2010104336 A3 WO 2010104336A3 KR 2010001516 W KR2010001516 W KR 2010001516W WO 2010104336 A3 WO2010104336 A3 WO 2010104336A3
Authority
WO
WIPO (PCT)
Prior art keywords
improved method
zinc powder
preparing meropenem
meropenem
preparing
Prior art date
Application number
PCT/KR2010/001516
Other languages
English (en)
French (fr)
Other versions
WO2010104336A2 (ko
Inventor
송윤석
박성우
윤연정
윤희균
문성철
이병구
최수진
전선아
Original Assignee
주식회사 대웅제약
대웅바이오 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 대웅제약, 대웅바이오 주식회사 filed Critical 주식회사 대웅제약
Priority to BRPI1009816-0A priority Critical patent/BRPI1009816A2/pt
Priority to MX2011009532A priority patent/MX2011009532A/es
Priority to US13/256,178 priority patent/US9233963B2/en
Priority to JP2011553952A priority patent/JP5656881B2/ja
Priority to EP10751027.3A priority patent/EP2407468B1/en
Priority to RU2011141429/04A priority patent/RU2490270C2/ru
Priority to CN201080011897.8A priority patent/CN102348710B/zh
Priority to ES10751027.3T priority patent/ES2477290T3/es
Publication of WO2010104336A2 publication Critical patent/WO2010104336A2/ko
Publication of WO2010104336A3 publication Critical patent/WO2010104336A3/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 카바페넴계 첨단 항생물질인 메로페넴·삼수화물[(1R,5S,6S)-2-[((2'S,4'S)-2'-디메틸아미노카르보질)피롤리딘-4'-일티오]-6-[(R)-1-히드록시에틸]-1-메틸카르바벤-2-엠-3-카르복실산, 삼수화물]의 개선된 합성방법에 관한 것이다.
PCT/KR2010/001516 2009-03-13 2010-03-11 아연 분말을 이용한 메로페넴의 개선된 제조방법 WO2010104336A2 (ko)

Priority Applications (8)

Application Number Priority Date Filing Date Title
BRPI1009816-0A BRPI1009816A2 (pt) 2009-03-13 2010-03-11 "método para preparar um composto."
MX2011009532A MX2011009532A (es) 2009-03-13 2010-03-11 Metodo mejorado para preparar meropenem usando polvo de zinc.
US13/256,178 US9233963B2 (en) 2009-03-13 2010-03-11 Method for preparing meropenem using zinc powder
JP2011553952A JP5656881B2 (ja) 2009-03-13 2010-03-11 亜鉛粉末を用いるメロペネムの改善された製造方法
EP10751027.3A EP2407468B1 (en) 2009-03-13 2010-03-11 Improved method for preparing meropenem using zinc powder
RU2011141429/04A RU2490270C2 (ru) 2009-03-13 2010-03-11 Улучшенный способ получения меропенема с применением цинкового порошка
CN201080011897.8A CN102348710B (zh) 2009-03-13 2010-03-11 利用锌粉制备美罗培南的改进方法
ES10751027.3T ES2477290T3 (es) 2009-03-13 2010-03-11 Método mejorado para preparar meropenem usando polvo de zinc

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090021622 2009-03-13
KR10-2009-0021622 2009-03-13

Publications (2)

Publication Number Publication Date
WO2010104336A2 WO2010104336A2 (ko) 2010-09-16
WO2010104336A3 true WO2010104336A3 (ko) 2010-12-23

Family

ID=42728952

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/001516 WO2010104336A2 (ko) 2009-03-13 2010-03-11 아연 분말을 이용한 메로페넴의 개선된 제조방법

Country Status (10)

Country Link
US (1) US9233963B2 (ko)
EP (1) EP2407468B1 (ko)
JP (1) JP5656881B2 (ko)
KR (1) KR101491871B1 (ko)
CN (1) CN102348710B (ko)
BR (1) BRPI1009816A2 (ko)
ES (1) ES2477290T3 (ko)
MX (1) MX2011009532A (ko)
RU (1) RU2490270C2 (ko)
WO (1) WO2010104336A2 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729260B2 (en) * 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102532140B (zh) * 2010-12-21 2015-03-11 北大方正集团有限公司 一种美罗培南三水合物的制备方法
JP2016501259A (ja) * 2012-12-04 2016-01-18 デーウン ファーマシューティカル カンパニー リミテッド 結晶性ドリペネム一水和物およびその製造方法
WO2014104488A1 (ko) * 2012-12-27 2014-07-03 제이더블유중외제약 주식회사 카바페넴계 항생제의 제조 방법
KR101331762B1 (ko) * 2012-12-28 2013-11-20 주식회사 대웅제약 메로페넴의 삼수화물의 제조방법
KR102144777B1 (ko) 2013-06-19 2020-08-18 제이더블유중외제약 주식회사 결정형 메로페넴 삼수화물의 제조방법
CN106699760B (zh) * 2016-12-30 2019-01-18 淄博鑫泉医药技术服务有限公司 美罗培南三水合物的合成方法
CN108191869A (zh) * 2018-01-22 2018-06-22 重庆天地药业有限责任公司 美罗培南的纯化方法
CN111992205B (zh) * 2020-09-07 2023-06-16 西安凯立新材料股份有限公司 一种一锅法制备美罗培南用催化剂的方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256377A1 (en) * 1986-07-30 1988-02-24 Sumitomo Pharmaceuticals Company, Limited Carbapenem compound in crystalline form, and its production and use
KR20020005334A (ko) * 2000-07-10 2002-01-17 박호군 신규 1-베타메틸카바페넴 유도체 및 그의 제조방법
KR20060020081A (ko) * 2004-08-31 2006-03-06 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
WO2006035300A2 (en) * 2004-09-30 2006-04-06 Ranbaxy Laboratories Limited A process for the preparation of meropenem
KR100781821B1 (ko) * 2006-02-16 2007-12-03 문순구 카르바페넴계 화합물의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
SU1577699A3 (ru) * 1985-04-29 1990-07-07 Бристоль-Мейерз Компани (Фирма) Способ получени производных карбапенема
JP2654076B2 (ja) * 1987-12-24 1997-09-17 日本レダリー株式会社 保護基の脱離方法
KR0136570B1 (ko) 1992-12-07 1998-04-25 채영복 메로페넴 화합물의 제조방법
JPH07258258A (ja) * 1994-03-15 1995-10-09 Yamanouchi Pharmaceut Co Ltd カルバペネム誘導体
HUP0400444A3 (en) * 2001-05-21 2007-02-28 Kyoto Pharmaceutical Ind Carbapenem compound, pharmaceutical compositions containing them and their use
JP5373390B2 (ja) * 2006-03-28 2013-12-18 株式会社カネカ カルバペネム化合物の改良された製造方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256377A1 (en) * 1986-07-30 1988-02-24 Sumitomo Pharmaceuticals Company, Limited Carbapenem compound in crystalline form, and its production and use
KR20020005334A (ko) * 2000-07-10 2002-01-17 박호군 신규 1-베타메틸카바페넴 유도체 및 그의 제조방법
KR20060020081A (ko) * 2004-08-31 2006-03-06 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
WO2006035300A2 (en) * 2004-09-30 2006-04-06 Ranbaxy Laboratories Limited A process for the preparation of meropenem
KR100781821B1 (ko) * 2006-02-16 2007-12-03 문순구 카르바페넴계 화합물의 제조방법

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2407468A4 *

Also Published As

Publication number Publication date
RU2011141429A (ru) 2013-04-20
EP2407468A2 (en) 2012-01-18
CN102348710B (zh) 2014-12-17
US9233963B2 (en) 2016-01-12
JP5656881B2 (ja) 2015-01-21
KR101491871B1 (ko) 2015-02-12
CN102348710A (zh) 2012-02-08
RU2490270C2 (ru) 2013-08-20
US20120065392A1 (en) 2012-03-15
ES2477290T3 (es) 2014-07-16
KR20100103427A (ko) 2010-09-27
EP2407468B1 (en) 2014-04-16
JP2012520293A (ja) 2012-09-06
BRPI1009816A2 (pt) 2015-08-25
WO2010104336A2 (ko) 2010-09-16
MX2011009532A (es) 2011-10-24
EP2407468A4 (en) 2012-09-05

Similar Documents

Publication Publication Date Title
WO2010104336A3 (ko) 아연 분말을 이용한 메로페넴의 개선된 제조방법
EP2388261A3 (en) Improved process for the preparation of carbapenem using carbapenem intermediates and recovery of carbapenem
WO2013052550A3 (en) Novel imidazole quinoline-based immune system modulators
AU2012334173A8 (en) [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
WO2009150630A3 (en) Compositions of carbon dioxide adduct of ertapenem and polymorphic forms of ertapenem monosodium salt
TW200801004A (en) Improved process for producing carbapenem compound
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
WO2012170735A3 (en) Physical layer frame format for long range wlan
NZ727045A (en) Camsylate salt of (1r,1’r,4r)- 4-methoxy-5’’-methyl-6’-[5-(prop-1-yn-1-yl)pyridin-3-yl]-3’h-dispiro[cyclohexane-1,2’-indene-1’,2’’-imidazol]-4’’-amine
WO2012042534A3 (en) Preparation of r-sitagliptin and intermediates thereof
WO2013014665A8 (en) Intermediate compounds and process for the preparation of lurasidone and salts thereof
WO2012079504A8 (zh) 一种碳青霉烯抗生素的制备方法
WO2009092702A3 (en) ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production employing a 2-deoxyribose-5-phosphate aldolase
WO2011142825A3 (en) Novel sulfur containing compounds
SG11201403356YA (en) 2 - (pyridin- 2yl) - 1, 7 -diaza-spiro [4.4] nonane- 6 -one compound as voltage-gated sodium channels modulator
AU2012283449A8 (en) Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
AU2012255352A1 (en) Stereospecific synthesis process for tretinoin compounds
WO2010009014A3 (en) Antibiotic drug
WO2011102640A3 (en) Method for preparing sitagliptin and amine salt intermediates used therein
EP2261317B8 (en) Microorganism producing cyclic compound
WO2011135586A3 (en) Process for the preparation of chiral beta amino carboxamide derivatives
TW200738718A (en) Process for production of intermediate for meropenem
EP2657305A4 (en) Water-based ink for inkjet recording, method of producing said water-based ink
WO2009122429A3 (en) Crystalline oxybutynin and process for preparing the same
MX2015011721A (es) Proceso para la preparacion de (2s,5r) -7-oxo-6-sulfooxi-2-[((3r)- pirrolidin-3-carbonil) carbonil hidrazino]-1,6-diaza-biciclo[3.2.1 ] octano.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080011897.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10751027

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010751027

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12011501722

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: MX/A/2011/009532

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2011553952

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2011141429

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13256178

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: PI1009816

Country of ref document: BR

ENP Entry into the national phase

Ref document number: PI1009816

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20110912